Eli Lilly and Company are conducting a Long-term Study to Assess the Safety and Efficacy of xxxxxxxxxxx in Patients With Moderate-to-Severe Atopic Dermatitis.
To participate in your local study, please contact (949) 844-0442 or fill out the form below.
Protocol # J2T-DM-KGAA/DRM06-AD07
Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.